252 related articles for article (PubMed ID: 35885958)
1. Identification of the Key miRNAs and Genes Associated with the Regulation of Non-Small Cell Lung Cancer: A Network-Based Approach.
Shafat Z; Ahmed MM; Almajhdi FN; Hussain T; Parveen S; Ahmed A
Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885958
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of mRNA and miRNA expression profiles reveals seven potential diagnostic biomarkers for non‑small cell lung cancer.
Zhang J; Li D; Zhang Y; Ding Z; Zheng Y; Chen S; Wan Y
Oncol Rep; 2020 Jan; 43(1):99-112. PubMed ID: 31746439
[TBL] [Abstract][Full Text] [Related]
3. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
4. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
5. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
[TBL] [Abstract][Full Text] [Related]
6. Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer.
Mitra R; Edmonds MD; Sun J; Zhao M; Yu H; Eischen CM; Zhao Z
RNA; 2014 Sep; 20(9):1356-68. PubMed ID: 25024357
[TBL] [Abstract][Full Text] [Related]
7. Gene-microRNA Network Analysis Identified Seven Hub Genes in Association with Progression and Prognosis in Non-Small Cell Lung Cancer.
Yang Z; Wang H; Zhao Z; Jin Y; Zhang Z; Tan J; Hu F
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011391
[TBL] [Abstract][Full Text] [Related]
8. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
Jin X; Guan Y; Zhang Z; Wang H
BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of circulating small extracellular vesicle-derived miRNAs as diagnostic biomarkers for differentiating between different pathological types of early lung cancer.
Jiang YF; Wei SN; Geng N; Qin WW; He X; Wang XH; Qi YP; Song S; Wang P
Sci Rep; 2022 Oct; 12(1):17201. PubMed ID: 36229645
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
Liao J; Shen J; Leng Q; Qin M; Zhan M; Jiang F
Thorac Cancer; 2020 Mar; 11(3):762-768. PubMed ID: 31994346
[TBL] [Abstract][Full Text] [Related]
12. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analysis of the circRNA-miRNA-mRNA network for non-small cell lung cancer.
Cai X; Lin L; Zhang Q; Wu W; Su A
J Int Med Res; 2020 Jun; 48(6):300060520929167. PubMed ID: 32527185
[TBL] [Abstract][Full Text] [Related]
14. MiRNA synergistic network construction and enrichment analysis for common target genes in small-cell lung cancer.
Zhang TF; Cheng KW; Shi WY; Zhang JT; Liu KD; Xu SG; Chen JQ
Asian Pac J Cancer Prev; 2012; 13(12):6375-8. PubMed ID: 23464461
[TBL] [Abstract][Full Text] [Related]
15. The oncogenic and prognostic potential of eight microRNAs identified by a synergetic regulatory network approach in lung cancer.
Mitra R; Zhao Z
Int J Comput Biol Drug Des; 2014; 7(4):384-93. PubMed ID: 25539849
[TBL] [Abstract][Full Text] [Related]
16. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
[TBL] [Abstract][Full Text] [Related]
17. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms.
Selvaraj G; Kaliamurthi S; Kaushik AC; Khan A; Wei YK; Cho WC; Gu K; Wei DQ
J Biomed Inform; 2018 Oct; 86():120-134. PubMed ID: 30195659
[TBL] [Abstract][Full Text] [Related]
18. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
[TBL] [Abstract][Full Text] [Related]
19. Potential circulating miRNA signature for early detection of NSCLC.
Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
